Apeiron RIA’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $539K | Sell |
260,378
-2,164
| -0.8% | -$4.48K | 0.14% | 118 |
|
|
2025
Q1 | $578K | Hold |
262,542
| – | – | 0.17% | 110 |
|
|
2024
Q4 | $402K | Buy |
262,542
+19,000
| +8% | +$29.1K | 0.11% | 138 |
|
|
2024
Q3 | $485K | Buy |
243,542
+54,907
| +29% | +$109K | 0.14% | 119 |
|
|
2024
Q2 | $660K | Buy |
188,635
+64,635
| +52% | +$226K | 0.2% | 88 |
|
|
2024
Q1 | $343K | Buy |
124,000
+41,000
| +49% | +$114K | 0.1% | 153 |
|
|
2023
Q4 | $141K | Hold |
83,000
| – | – | 0.04% | 198 |
|
|
2023
Q3 | $85.5K | Buy |
83,000
+31,000
| +60% | +$31.9K | 0.03% | 189 |
|
|
2023
Q2 | $60.3K | Buy |
52,000
+19,000
| +58% | +$22K | 0.02% | 191 |
|
|
2023
Q1 | $49.8K | Buy |
+33,000
| New | +$49.8K | 0.02% | 193 |
|